ArticleClinical and experimental immunology2016

The complement receptor 3 (CD11b/CD18) agonist Leukadherin-1 suppresses human innate inflammatory signalling.

A L Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.